Provide for a Prime Contractor to establish and monitor a subcontractor network necessary to perform preclinical toxicology studies suitable for Investigational New Drug Application filing with the Food and Drug Administration.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM017365-021
Application #
2299859
Study Section
Project Start
1980-11-21
Project End
1987-11-30
Budget Start
1985-06-11
Budget End
1985-11-30
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Battelle Memorial Institute
Department
Type
DUNS #
City
Columbus
State
OH
Country
United States
Zip Code
43201
Conley, B A; Sewack, G F; Egorin, M J et al. (1991) The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide. Cancer Chemother Pharmacol 28:33-8
Smith, A C; Liao, J T; Page, J G et al. (1989) Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Cancer Res 49:5385-91
Smith, A C; Barrett, D; Stedham, M A et al. (1987) Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer. Cancer Treat Rep 71:1157-64
Palmer, T E; Glaza, S M; Dickie, B C et al. (1985) Toxicity studies on the radioprotective agent WR-2721 in CDF1 mice and beagle dogs. Toxicol Pathol 13:58-65